EP3283521
Lyfjasamtengingar sem innihalda mótefni gegn claudin 18.2
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.4.2016EP published:
15.11.2023EP application number:
16715583.7
EP translation filed:
12.12.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
12.4.2036Expiry date:
12.4.2026Next due date:
30.4.2026
Title in English:
DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2Language of the patent:
English
Timeline
Today
13.4.2016EP application
15.11.2023EP Publication
12.12.2023Translation submitted
15.1.2024Registration published
12.4.2026Expires
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP
Name:
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbHAddress:
Freiligrathstrasse 12, 55131 Mainz, DE
Inventor
Name:
SAHIN, UgurAddress:
55116 Mainz, DE
Name:
TÜRECI, ÖzlemAddress:
55116 Mainz, DE
Name:
WALTER, KordenAddress:
55291 Saulheim, DE
Name:
KREUZBERG, MariaAddress:
55131 Mainz, DE
Name:
MITNACHT-KRAUS, RitaAddress:
61169 Friedberg, DE
Name:
LE GALL, FabriceAddress:
55122 Mainz, DE
Name:
JACOBS, StefanAddress:
55128 Mainz, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2015/058206Date:
15.4.2015Country:
WO
Classification
Categories:
C07K 16/28, C07K 16/30, A61K 47/68, A61P 35/00, A61K 31/40
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 19.3.2024
Expires: 12.4.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 14.4.2025
Expires: 12.4.2026
Payer: Árnason Faktor ehf.